Levothyroxine Sodium Tablet
Product Images NDC 72865-241

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 72865-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 100 mcg (0.1 mg) by XLCare Pharmaceuticals, Inc. The label shows the NDC 72865-240-10 and states the package contains 1000 tablets for oral use. It includes storage, dispensing, and manufacturing details by Ascent Pharmaceuticals and XLCare Pharmaceuticals.*

FDA Label Image

100 Mcg (90 count)

Levothyroxine Sodium Tablets, USP 100 mcg (0.1 mg) oral tablets packaged by XLCare Pharmaceuticals, Inc. The label shows a bottle containing 90 tablets with a child-resistant closure. The label includes storage instructions, manufacturer details, and a barcode. This is a human prescription drug for oral use.*

FDA Label Image

112 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 112 mcg (0.112 mg) oral tablets by XLCare Pharmaceuticals, Inc. The label indicates a package size of 1000 tablets and includes storage instructions, manufacturer and labeler information, and a barcode. Strength is displayed in a pink box.*

FDA Label Image

112 Mcg (90 count)

LEVOTHYROXINE SODIUM Tablets, USP 0.112 mg (112 mcg) oral tablets, displayed on the label from XLCare Pharmaceuticals, Inc. The label shows a 90-tablet bottle and includes storage conditions, handling instructions, and the manufacturers' addresses. NDC 72865-241-90.*

FDA Label Image

125 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) oral tablets by XLCare Pharmaceuticals, Inc. The package contains 1000 tablets, Rx only. The label includes storage instructions, manufacturer and labeler information, and notes each tablet contains levothyroxine sodium USP 125 mcg.*

FDA Label Image

125 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) oral tablets by XLCare Pharmaceuticals, Inc. The package contains 90 tablets with an Rx Only designation. The label includes handling instructions and manufacturing information for Ascent Pharmaceuticals, Inc. and XLCare Pharmaceuticals, Inc.*

FDA Label Image

137 Mcg (1000 count)

Packaging label for Levothyroxine Sodium Tablets, USP 137 mcg (0.137 mg) oral tablets by XLCare Pharmaceuticals, Inc. The label indicates a bottle containing 1000 tablets for prescription use only. Storage and handling instructions along with manufacturer and labeler details are provided.*

FDA Label Image

137 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 137 mcg (0.137 mg) by XLCare Pharmaceuticals, Inc. The label states the package contains 90 tablets for oral use. It includes storage instructions, manufacturing details by Ascent Pharmaceuticals, Inc., and prescription-only designation. The label features a barcode and states the product is unvarnished.*

FDA Label Image

150 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg) orally administered tablets by XLCare Pharmaceuticals, Inc. The label indicates a quantity of 1000 tablets, with prescribing, storage, and manufacturing information. It includes the NDC 72865-244-10 and specifies tight, light-resistant container storage and temperature conditions. Manufactured by Ascent Pharmaceuticals and labeled for XLCare Pharmaceuticals, Inc.*

FDA Label Image

150 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg) by XLCare Pharmaceuticals, Inc. The label shows the NDC 72865-244-90 and indicates a package of 90 tablets for oral use. It includes storage instructions, handling precautions, and manufacturer details for Ascent Pharmaceuticals, Inc. and XLCare Pharmaceuticals, Inc.*

FDA Label Image

175 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 175 mcg (0.175 mg) oral tablets by XLCare Pharmaceuticals, Inc. The package contains 1000 tablets for prescription use only. It includes storage instructions, manufacturer information (Ascent Pharmaceuticals, Inc.), and directions to store at controlled room temperature and protect from moisture and light.*

FDA Label Image

175 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 175 mcg (0.175 mg) by XLCare Pharmaceuticals, Inc. The bottle contains 90 tablets for oral use. The label includes storage instructions, manufacturer information, and a barcode on the side. It is marked Rx Only.*

FDA Label Image

200 Mcg (1000 count)

Levothyroxine Sodium Tablets, USP 200 mcg (0.2 mg) oral tablets in a 1000-tablet package by XL Care Pharmaceuticals, Inc. The label includes NDC 72865-246-10 and advises storage at controlled room temperature, protection from moisture and light. The product is Rx only and manufactured by Ascent Pharmaceuticals, Inc.*

FDA Label Image

200 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 200 mcg (0.2 mg) oral tablets by XLCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets, prescription only. The label includes storage instructions, manufacturer and labeler information, barcode, and lot details.*

FDA Label Image

25 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 25 mcg (0.025 mg) by XL Care Pharmaceuticals, Inc. The label indicates a package of 1000 oral tablets. It includes storage instructions, manufacturer and labeler details, and dosage information per tablet.*

FDA Label Image

25 Mcg (90 count)

LEVOTHYROXINE SODIUM Tablets, USP 25 mcg (0.025 mg) oral tablets label by XLCare Pharmaceuticals, Inc. This carton contains 90 tablets and is labeled Rx Only. The label provides storage instructions, dosage form, and manufacturer information, including Ascent Pharmaceuticals, Inc. and XLCare Pharmaceuticals, Inc.*

FDA Label Image

300 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 300 mcg (0.3 mg) oral tablets by XLCare Pharmaceuticals, Inc. The label indicates a package containing 1000 tablets with prescription only status. It includes storage instructions, manufacturer details, and the NDC number 72865-247-10.*

FDA Label Image

300 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 300 mcg (0.3 mg) oral tablets by XLCare Pharmaceuticals, Inc. The container holds 90 tablets. The label includes storage instructions, manufacturer details, barcode, and notes the product is Rx only.*

FDA Label Image

50 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets, USP 50 mcg (0.05 mg) oral tablets by XLCare Pharmaceuticals Inc. The package contains 1000 tablets, Rx only. Additional label text includes storage instructions, manufacturer details (Ascent Pharmaceuticals, Inc., Central Islip, NY), and distributor information (XLCare Pharmaceuticals, Inc., Lawrenceville, GA).*

FDA Label Image

50 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 50 mcg (0.05 mg) by XLCare Pharmaceuticals, Inc. The oral tablet packaging displays the NDC 72865-237-90 and indicates a 90-tablet count. It includes storage instructions, manufacturer details (Ascent Pharmaceuticals, Inc.), and is marked Rx only.*

FDA Label Image

75 Mcg (1000 count)

Label for Levothyroxine Sodium Tablets USP 75 mcg (0.075 mg) in tablet form by XL Care Pharmaceuticals Inc. The package contains 1000 tablets with the NDC 72865-238-10. The label includes storage instructions, manufacturing details, and states the product is Rx only.*

FDA Label Image

75 Mcg (90 count)

Label for Levothyroxine Sodium Tablets USP 75 mcg (0.075 mg) by XLCare Pharmaceuticals, Inc. The label indicates a package of 90 oral tablets with the NDC number 72865-238-90. It includes storage instructions, manufacturer details, and a note that the medication is prescription only.*

FDA Label Image

88 Mcg (1000 count)

Label for LEVOTHYROXINE SODIUM Tablets, USP 88 mcg (0.088 mg) oral tablets by XLCare Pharmaceuticals, Inc. The label indicates a quantity of 1000 tablets and Rx only. Storage instructions include temperature control and protection from moisture and light. The label states the drug is manufactured by Ascent Pharmaceuticals, Inc. and marketed by XLCare Pharmaceuticals, Inc.*

FDA Label Image

88 Mcg (90 count)

Label for Levothyroxine Sodium Tablets, USP 88 mcg (0.088 mg) by XLCare Pharmaceuticals, Inc. The package contains 90 tablets for oral use. The label includes storage instructions, manufacturer details, and a barcode. The labeling directs dispensing in a child-resistant container and notes the prescription-only status.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of levothyroxine sodium depicting the two iodinated aromatic rings connected by an ether linkage, with an amino acid side chain including an amine group (NH2) and a carboxylate group (COONa) bound to sodium and associated with water molecules (xH2O).*

FDA Label Image

Table1 (Table1)

A dosing guidelines table for Levothyroxine Sodium tablets in pediatric hypothyroidism. It lists age groups from 0-3 months up to greater than 12 years, with corresponding daily dose ranges in mcg/kg body weight. Additional notes clarify dose adjustment based on clinical response and laboratory parameters, including a dose for growth and puberty complete stage.*

FDA Label Image

Table 2 (Table2)

Table titled 'Drugs That May Decrease T4 Absorption (Hypothyroidism)' listing drug or drug classes such as Calcium Carbonate, Ferrous Sulfate, Orlistat, Bile Acid Sequestrants (including Colesevelam, Cholestyramine, Colestipol), Ion Exchange Resins (Kayexalate, Sevelamer), and other drugs like Proton Pump Inhibitors, Sucralfate, Antacids (Aluminum and Magnesium Hydroxides), and Simethicone, along with their potential impact on levothyroxine sodium absorption and related monitoring recommendations.*

FDA Label Image

Table3 (Table3)

A data table listing drugs that may alter T4 and Triiodothyronine (T3) serum transport without affecting free thyroxine (FT4) concentration in euthyroidism. It categorizes drugs by class, describes their effects on serum thyroxine-binding globulin (TBG) concentration, and notes the impact on levothyroxine sodium tablets' serum levels during administration.*

FDA Label Image

Table4 (Table4)

Table titled 'Drugs That May Alter Hepatic Metabolism of T4 (Hypothyroidism)' listing drug or drug class and their effects on levothyroxine metabolism. The table includes phenobarbital and rifampin, detailing their impact on hepatic enzyme activity and levothyroxine degradation.*

FDA Label Image

Table5 (Table5)

Table titled 'Drugs That May Decrease Conversion of T4 to T3' listing drug classes and their effects on thyroid hormone levels. It includes beta-adrenergic antagonists, glucocorticoids, and amiodarone, describing their impact on T3, T4, and related hormone levels in patients.*

FDA Label Image

Table6 (Table6)

A data table listing color additives used in levothyroxine sodium tablets by strength (micrograms). The table matches various FD&C and D&C color additives to specific tablet strengths, ranging from 25 mcg to 300 mcg, for this oral tablet product by XLCare Pharmaceuticals, Inc.*

FDA Label Image

Table7 (Table7)

A data table titled 'Pharmacokinetic Parameters of Thyroid Hormones in Euthyroid Patients' comparing levothyroxine (T4) and liothyronine (T3) on measures including ratio in thyroglobulin, biologic potency, half-life in days, and protein binding percentage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.